Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine for recovery and agitation after FESS
NCT04472689Unknown
- Sponsor
- Alexandria University
- Start
- Jul 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in Emergence agitation (EA) (2 arms), sponsored by Alexandria University. Primary endpoints: Quality of Recovery-40 at 48 hours and Emergence Agitation. Status: unknown.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT04472689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04472689.